| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 349 | 2025 | 6979 | 22.880 |
Why?
|
| CpG Islands | 77 | 2024 | 1211 | 11.190 |
Why?
|
| Microsatellite Instability | 93 | 2024 | 726 | 11.150 |
Why?
|
| DNA Methylation | 101 | 2024 | 4425 | 6.880 |
Why?
|
| Pathology, Molecular | 18 | 2022 | 329 | 6.330 |
Why?
|
| Colonic Neoplasms | 58 | 2024 | 2544 | 5.730 |
Why?
|
| Proto-Oncogene Proteins B-raf | 75 | 2024 | 2072 | 5.590 |
Why?
|
| Fusobacterium nucleatum | 12 | 2024 | 176 | 4.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 26 | 2020 | 333 | 3.690 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 21 | 2024 | 1104 | 3.430 |
Why?
|
| Epidemiology | 9 | 2019 | 280 | 3.390 |
Why?
|
| Cyclooxygenase 2 | 19 | 2020 | 599 | 3.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 35 | 2024 | 906 | 3.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 53 | 2024 | 1766 | 2.980 |
Why?
|
| Phosphatidylinositol 3-Kinases | 31 | 2021 | 2884 | 2.960 |
Why?
|
| Mutation | 107 | 2024 | 30235 | 2.810 |
Why?
|
| ras Proteins | 33 | 2014 | 1058 | 2.510 |
Why?
|
| Tumor Microenvironment | 27 | 2024 | 3939 | 2.460 |
Why?
|
| Carcinoma, Signet Ring Cell | 6 | 2018 | 82 | 2.360 |
Why?
|
| Adenoma | 29 | 2024 | 2163 | 2.190 |
Why?
|
| Carcinoma | 15 | 2020 | 2341 | 2.150 |
Why?
|
| Aspirin | 24 | 2024 | 3139 | 2.100 |
Why?
|
| Molecular Epidemiology | 11 | 2021 | 473 | 2.070 |
Why?
|
| Colonic Polyps | 16 | 2023 | 557 | 1.890 |
Why?
|
| Prospective Studies | 168 | 2025 | 54913 | 1.870 |
Why?
|
| Prognosis | 100 | 2024 | 30031 | 1.830 |
Why?
|
| Adenocarcinoma, Mucinous | 8 | 2014 | 526 | 1.750 |
Why?
|
| DNA, Neoplasm | 19 | 2013 | 1749 | 1.740 |
Why?
|
| Proportional Hazards Models | 66 | 2024 | 12561 | 1.710 |
Why?
|
| Adenocarcinoma | 33 | 2023 | 6400 | 1.710 |
Why?
|
| Muscular Atrophy, Spinal | 13 | 2010 | 261 | 1.650 |
Why?
|
| Proto-Oncogene Proteins | 32 | 2018 | 4534 | 1.610 |
Why?
|
| beta Catenin | 15 | 2020 | 1048 | 1.550 |
Why?
|
| Humans | 554 | 2025 | 768369 | 1.540 |
Why?
|
| Aged | 245 | 2024 | 171514 | 1.510 |
Why?
|
| Diet | 34 | 2024 | 8098 | 1.500 |
Why?
|
| Genes, ras | 10 | 2021 | 666 | 1.480 |
Why?
|
| Female | 370 | 2025 | 396926 | 1.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 41 | 2021 | 8636 | 1.420 |
Why?
|
| Middle Aged | 276 | 2025 | 223406 | 1.400 |
Why?
|
| Male | 329 | 2025 | 364761 | 1.380 |
Why?
|
| Disease | 4 | 2016 | 672 | 1.380 |
Why?
|
| Body Mass Index | 31 | 2024 | 13030 | 1.370 |
Why?
|
| Neoplasms | 26 | 2024 | 22389 | 1.350 |
Why?
|
| Colon | 18 | 2021 | 1804 | 1.340 |
Why?
|
| Follow-Up Studies | 98 | 2024 | 39429 | 1.260 |
Why?
|
| Microsatellite Repeats | 14 | 2016 | 784 | 1.240 |
Why?
|
| Rectal Neoplasms | 10 | 2021 | 1179 | 1.200 |
Why?
|
| Biostatistics | 4 | 2020 | 165 | 1.180 |
Why?
|
| Epigenomics | 7 | 2019 | 958 | 1.180 |
Why?
|
| Bacteroides fragilis | 3 | 2024 | 250 | 1.170 |
Why?
|
| Polymerase Chain Reaction | 25 | 2014 | 6087 | 1.160 |
Why?
|
| Risk Factors | 149 | 2025 | 74915 | 1.160 |
Why?
|
| Folic Acid | 8 | 2024 | 1336 | 1.160 |
Why?
|
| Feeding Behavior | 16 | 2021 | 3202 | 1.150 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2024 | 1813 | 1.150 |
Why?
|
| Phenotype | 48 | 2024 | 16712 | 1.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2012 | 379 | 1.130 |
Why?
|
| Loss of Heterozygosity | 12 | 2018 | 663 | 1.120 |
Why?
|
| Pancreatic Neoplasms | 28 | 2022 | 5443 | 1.100 |
Why?
|
| Neoplasm Staging | 42 | 2024 | 11249 | 1.100 |
Why?
|
| Insulin-Like Growth Factor II | 11 | 2019 | 268 | 1.050 |
Why?
|
| Cohort Studies | 78 | 2024 | 41782 | 1.040 |
Why?
|
| Nerve Tissue Proteins | 17 | 2011 | 4417 | 1.030 |
Why?
|
| DNA, Bacterial | 5 | 2021 | 1474 | 1.030 |
Why?
|
| Kaplan-Meier Estimate | 29 | 2020 | 6537 | 1.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2024 | 321 | 1.020 |
Why?
|
| Incidence | 55 | 2025 | 21552 | 1.010 |
Why?
|
| Lymphocytes | 6 | 2020 | 2611 | 1.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 13 | 2024 | 2279 | 1.010 |
Why?
|
| Polymorphism, Single Nucleotide | 41 | 2024 | 16023 | 0.960 |
Why?
|
| Immunohistochemistry | 43 | 2021 | 11139 | 0.950 |
Why?
|
| Mendelian Randomization Analysis | 12 | 2024 | 1036 | 0.920 |
Why?
|
| Genetic Predisposition to Disease | 43 | 2024 | 18047 | 0.870 |
Why?
|
| Fusobacterium Infections | 2 | 2021 | 54 | 0.860 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2017 | 595 | 0.860 |
Why?
|
| Adult | 175 | 2025 | 223528 | 0.850 |
Why?
|
| Intestinal Mucosa | 10 | 2020 | 3047 | 0.830 |
Why?
|
| Gene Silencing | 10 | 2010 | 1502 | 0.830 |
Why?
|
| Causality | 6 | 2021 | 1255 | 0.820 |
Why?
|
| Vitamin D | 10 | 2021 | 3311 | 0.800 |
Why?
|
| Paraffin Embedding | 4 | 2020 | 306 | 0.800 |
Why?
|
| Metalloendopeptidases | 1 | 2024 | 389 | 0.790 |
Why?
|
| Genetic Testing | 15 | 2010 | 3586 | 0.790 |
Why?
|
| Adiponectin | 7 | 2024 | 1118 | 0.770 |
Why?
|
| Keloid | 1 | 2022 | 55 | 0.770 |
Why?
|
| Coffee | 3 | 2022 | 598 | 0.760 |
Why?
|
| Lymphocyte Count | 8 | 2022 | 791 | 0.750 |
Why?
|
| DNA Modification Methylases | 5 | 2019 | 210 | 0.750 |
Why?
|
| Survival Analysis | 26 | 2021 | 10127 | 0.740 |
Why?
|
| Neoplasm Proteins | 9 | 2020 | 3611 | 0.740 |
Why?
|
| Promoter Regions, Genetic | 13 | 2016 | 5803 | 0.740 |
Why?
|
| Terminology as Topic | 3 | 2021 | 1539 | 0.740 |
Why?
|
| RNA-Binding Proteins | 18 | 2024 | 1885 | 0.730 |
Why?
|
| Case-Control Studies | 53 | 2024 | 22286 | 0.730 |
Why?
|
| Bifidobacterium | 3 | 2021 | 99 | 0.730 |
Why?
|
| Alcohol Drinking | 15 | 2024 | 4052 | 0.710 |
Why?
|
| Colonoscopy | 18 | 2025 | 1412 | 0.710 |
Why?
|
| SMN Complex Proteins | 14 | 2004 | 41 | 0.710 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2020 | 182 | 0.710 |
Why?
|
| Odds Ratio | 28 | 2022 | 9687 | 0.700 |
Why?
|
| DNA Repair Enzymes | 5 | 2019 | 347 | 0.690 |
Why?
|
| Tumor Suppressor Protein p53 | 14 | 2020 | 2964 | 0.680 |
Why?
|
| Tissue Fixation | 3 | 2020 | 245 | 0.670 |
Why?
|
| Obesity | 20 | 2024 | 13065 | 0.670 |
Why?
|
| Models, Educational | 2 | 2012 | 375 | 0.670 |
Why?
|
| Survival Rate | 25 | 2019 | 12875 | 0.650 |
Why?
|
| Bayes Theorem | 8 | 2020 | 2359 | 0.650 |
Why?
|
| Pathology | 2 | 2012 | 270 | 0.650 |
Why?
|
| Formaldehyde | 3 | 2020 | 361 | 0.650 |
Why?
|
| T-Lymphocytes | 10 | 2023 | 10269 | 0.640 |
Why?
|
| Bifidobacteriales Infections | 1 | 2018 | 10 | 0.640 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2020 | 959 | 0.640 |
Why?
|
| Selection Bias | 3 | 2021 | 360 | 0.630 |
Why?
|
| Precancerous Conditions | 5 | 2021 | 988 | 0.630 |
Why?
|
| Gene Dosage | 9 | 2011 | 1221 | 0.620 |
Why?
|
| Risk Assessment | 46 | 2024 | 24310 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 18 | 6 | 2009 | 247 | 0.620 |
Why?
|
| DNA Mutational Analysis | 15 | 2022 | 4120 | 0.620 |
Why?
|
| Smoking | 18 | 2024 | 9099 | 0.620 |
Why?
|
| Neoplasm Recurrence, Local | 17 | 2022 | 9425 | 0.620 |
Why?
|
| Rectum | 11 | 2020 | 902 | 0.610 |
Why?
|
| Multivariate Analysis | 29 | 2021 | 12096 | 0.610 |
Why?
|
| Escherichia coli Infections | 1 | 2022 | 524 | 0.600 |
Why?
|
| Sigmoidoscopy | 6 | 2022 | 151 | 0.600 |
Why?
|
| Chromosomal Instability | 2 | 2009 | 178 | 0.600 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 6 | 2013 | 319 | 0.600 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2011 | 306 | 0.590 |
Why?
|
| Life Style | 17 | 2024 | 3929 | 0.590 |
Why?
|
| Tumor Escape | 2 | 2018 | 374 | 0.590 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 558 | 0.580 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 14 | 2004 | 501 | 0.580 |
Why?
|
| Interdisciplinary Communication | 3 | 2020 | 937 | 0.570 |
Why?
|
| Epigenesis, Genetic | 10 | 2014 | 3832 | 0.570 |
Why?
|
| Exercise Therapy | 2 | 2015 | 941 | 0.570 |
Why?
|
| Genes, p53 | 4 | 2009 | 716 | 0.570 |
Why?
|
| Metabolome | 3 | 2024 | 1009 | 0.560 |
Why?
|
| Logistic Models | 26 | 2024 | 13323 | 0.560 |
Why?
|
| United States | 68 | 2025 | 73120 | 0.550 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 783 | 0.550 |
Why?
|
| Survival of Motor Neuron 1 Protein | 11 | 2004 | 64 | 0.540 |
Why?
|
| Vitamins | 4 | 2024 | 1638 | 0.540 |
Why?
|
| Forkhead Transcription Factors | 3 | 2020 | 1625 | 0.520 |
Why?
|
| Fatty Acids, Omega-3 | 7 | 2020 | 1398 | 0.510 |
Why?
|
| MicroRNAs | 3 | 2016 | 3806 | 0.510 |
Why?
|
| DNA Mismatch Repair | 6 | 2024 | 433 | 0.500 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2019 | 2819 | 0.500 |
Why?
|
| Folic Acid Deficiency | 2 | 2015 | 117 | 0.490 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2022 | 4613 | 0.490 |
Why?
|
| Disease-Free Survival | 20 | 2024 | 6856 | 0.490 |
Why?
|
| Germ-Line Mutation | 10 | 2024 | 1884 | 0.490 |
Why?
|
| Receptors, Calcitriol | 3 | 2016 | 361 | 0.490 |
Why?
|
| Genome-Wide Association Study | 21 | 2024 | 12771 | 0.480 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2023 | 388 | 0.480 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2007 | 451 | 0.480 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2016 | 2847 | 0.480 |
Why?
|
| Age of Onset | 9 | 2024 | 3342 | 0.470 |
Why?
|
| Dietary Fiber | 4 | 2020 | 767 | 0.470 |
Why?
|
| Autophagy | 2 | 2020 | 1349 | 0.460 |
Why?
|
| Sulfites | 4 | 2010 | 83 | 0.450 |
Why?
|
| Hematoxylin | 2 | 2020 | 61 | 0.450 |
Why?
|
| Eosine Yellowish-(YS) | 2 | 2020 | 70 | 0.450 |
Why?
|
| Lymph Nodes | 4 | 2017 | 3472 | 0.450 |
Why?
|
| Tissue Array Analysis | 6 | 2015 | 551 | 0.450 |
Why?
|
| Early Detection of Cancer | 9 | 2025 | 3230 | 0.450 |
Why?
|
| Survival of Motor Neuron 2 Protein | 9 | 2004 | 49 | 0.440 |
Why?
|
| Prostaglandin Antagonists | 1 | 2013 | 28 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 12 | 2014 | 4774 | 0.440 |
Why?
|
| Science | 1 | 2016 | 239 | 0.440 |
Why?
|
| Models, Statistical | 5 | 2024 | 5103 | 0.430 |
Why?
|
| Lymphatic Metastasis | 5 | 2020 | 2930 | 0.430 |
Why?
|
| Tooth Loss | 3 | 2020 | 200 | 0.430 |
Why?
|
| Genomic Instability | 4 | 2012 | 714 | 0.430 |
Why?
|
| Gene Conversion | 2 | 2003 | 69 | 0.430 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2024 | 11844 | 0.420 |
Why?
|
| Neuroendocrine Tumors | 5 | 2018 | 650 | 0.420 |
Why?
|
| Nurses | 15 | 2021 | 2494 | 0.420 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 5 | 2012 | 57 | 0.410 |
Why?
|
| Immunoenzyme Techniques | 6 | 2015 | 1706 | 0.410 |
Why?
|
| Carcinoma, Pancreatic Ductal | 7 | 2020 | 1755 | 0.400 |
Why?
|
| Codon | 1 | 2014 | 598 | 0.400 |
Why?
|
| Vitamin B 6 | 3 | 2014 | 234 | 0.400 |
Why?
|
| Cyclin D1 | 2 | 2017 | 454 | 0.400 |
Why?
|
| Cystic Fibrosis | 4 | 2005 | 1287 | 0.400 |
Why?
|
| Genomics | 8 | 2024 | 5912 | 0.390 |
Why?
|
| Smad7 Protein | 3 | 2021 | 39 | 0.390 |
Why?
|
| Public Health | 4 | 2020 | 2693 | 0.390 |
Why?
|
| Up-Regulation | 8 | 2019 | 4132 | 0.380 |
Why?
|
| Cyclin-Dependent Kinase 8 | 2 | 2010 | 49 | 0.370 |
Why?
|
| Liver Neoplasms | 5 | 2023 | 4362 | 0.370 |
Why?
|
| Calcium, Dietary | 3 | 2019 | 533 | 0.370 |
Why?
|
| Lactones | 1 | 2013 | 316 | 0.370 |
Why?
|
| Body Size | 2 | 2024 | 463 | 0.370 |
Why?
|
| RNA | 2 | 2021 | 2728 | 0.370 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2024 | 1209 | 0.370 |
Why?
|
| Camptothecin | 7 | 2014 | 594 | 0.360 |
Why?
|
| Sulfones | 1 | 2013 | 448 | 0.360 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 829 | 0.360 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.360 |
Why?
|
| Waist-Hip Ratio | 3 | 2024 | 520 | 0.360 |
Why?
|
| Genes, p16 | 1 | 2011 | 160 | 0.360 |
Why?
|
| Methionine | 3 | 2014 | 574 | 0.360 |
Why?
|
| Cathepsin B | 1 | 2010 | 81 | 0.350 |
Why?
|
| Genetic Heterogeneity | 3 | 2021 | 738 | 0.350 |
Why?
|
| Motor Activity | 4 | 2015 | 2722 | 0.350 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.350 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 734 | 0.350 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.340 |
Why?
|
| Risk | 18 | 2021 | 9642 | 0.340 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 1170 | 0.340 |
Why?
|
| Genes, bcl-1 | 1 | 2009 | 11 | 0.340 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2009 | 69 | 0.340 |
Why?
|
| Leucovorin | 6 | 2014 | 643 | 0.340 |
Why?
|
| Exercise | 8 | 2023 | 5940 | 0.340 |
Why?
|
| Coloring Agents | 1 | 2012 | 564 | 0.340 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 4582 | 0.330 |
Why?
|
| Social Environment | 1 | 2015 | 1026 | 0.330 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2020 | 384 | 0.330 |
Why?
|
| Seafood | 3 | 2018 | 395 | 0.330 |
Why?
|
| Vitamin B Complex | 2 | 2008 | 299 | 0.330 |
Why?
|
| Staining and Labeling | 2 | 2020 | 1083 | 0.330 |
Why?
|
| Rhabdoid Tumor | 3 | 2001 | 210 | 0.330 |
Why?
|
| Sirtuins | 2 | 2009 | 322 | 0.320 |
Why?
|
| Genotype | 21 | 2024 | 13045 | 0.320 |
Why?
|
| Stathmin | 1 | 2009 | 70 | 0.320 |
Why?
|
| Fluorouracil | 8 | 2018 | 1656 | 0.320 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2006 | 83 | 0.310 |
Why?
|
| Dietary Supplements | 9 | 2024 | 3445 | 0.310 |
Why?
|
| Sex Factors | 16 | 2024 | 10647 | 0.310 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 324 | 0.310 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2009 | 153 | 0.310 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 287 | 0.310 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3854 | 0.300 |
Why?
|
| Heterozygote | 4 | 2022 | 2792 | 0.300 |
Why?
|
| Cetirizine | 2 | 2008 | 7 | 0.300 |
Why?
|
| Chemotherapy, Adjuvant | 11 | 2024 | 3550 | 0.300 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 2 | 2008 | 17 | 0.300 |
Why?
|
| Blood Cells | 1 | 2010 | 308 | 0.290 |
Why?
|
| RecQ Helicases | 1 | 2007 | 53 | 0.290 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 617 | 0.290 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 527 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2016 | 2910 | 0.290 |
Why?
|
| Fusobacterium | 3 | 2021 | 56 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2011 | 711 | 0.290 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2020 | 130 | 0.290 |
Why?
|
| Dairy Products | 2 | 2021 | 490 | 0.290 |
Why?
|
| Progestins | 2 | 2022 | 302 | 0.290 |
Why?
|
| Stomach Neoplasms | 6 | 2020 | 1484 | 0.290 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2008 | 115 | 0.280 |
Why?
|
| Epidemiologic Methods | 4 | 2015 | 1337 | 0.280 |
Why?
|
| Proteins | 2 | 2021 | 6009 | 0.280 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 598 | 0.280 |
Why?
|
| Wnt Proteins | 5 | 2015 | 724 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.270 |
Why?
|
| Research Design | 5 | 2016 | 6217 | 0.270 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 873 | 0.270 |
Why?
|
| Flavonoids | 2 | 2023 | 447 | 0.270 |
Why?
|
| Aged, 80 and over | 37 | 2024 | 59679 | 0.270 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 191 | 0.270 |
Why?
|
| Immunologic Tests | 1 | 2007 | 104 | 0.260 |
Why?
|
| Environmental Exposure | 2 | 2015 | 4533 | 0.260 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 621 | 0.260 |
Why?
|
| Genetic Loci | 6 | 2024 | 2630 | 0.260 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 1892 | 0.260 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2017 | 318 | 0.260 |
Why?
|
| Histocytochemistry | 2 | 2024 | 699 | 0.260 |
Why?
|
| Genetic Counseling | 3 | 2004 | 633 | 0.260 |
Why?
|
| PPAR gamma | 1 | 2008 | 487 | 0.260 |
Why?
|
| Mucins | 2 | 2013 | 570 | 0.250 |
Why?
|
| Interleukin-6 | 8 | 2024 | 3234 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 4 | 2016 | 348 | 0.250 |
Why?
|
| Gene Deletion | 7 | 2016 | 2674 | 0.250 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 2002 | 46 | 0.250 |
Why?
|
| Diabetes Mellitus | 5 | 2022 | 5887 | 0.250 |
Why?
|
| Smoking Cessation | 2 | 2017 | 2078 | 0.250 |
Why?
|
| Neoplasms, Second Primary | 1 | 2013 | 1062 | 0.250 |
Why?
|
| Trypsinogen | 1 | 2005 | 84 | 0.250 |
Why?
|
| Biomedical Research | 3 | 2020 | 3463 | 0.250 |
Why?
|
| Calcium Channels, T-Type | 3 | 2011 | 28 | 0.240 |
Why?
|
| Fishes | 3 | 2020 | 605 | 0.240 |
Why?
|
| Periodontal Diseases | 2 | 2020 | 455 | 0.240 |
Why?
|
| Exons | 8 | 2023 | 2392 | 0.240 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2007 | 604 | 0.240 |
Why?
|
| Mucous Membrane | 2 | 2019 | 660 | 0.240 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2015 | 199 | 0.240 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2019 | 269 | 0.240 |
Why?
|
| Pathology, Clinical | 2 | 2024 | 377 | 0.230 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 243 | 0.230 |
Why?
|
| Ethanol | 3 | 2019 | 1334 | 0.230 |
Why?
|
| Time Factors | 22 | 2021 | 40271 | 0.230 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2020 | 3253 | 0.230 |
Why?
|
| Genes, Dominant | 1 | 2007 | 856 | 0.230 |
Why?
|
| Antineoplastic Agents | 12 | 2018 | 13709 | 0.230 |
Why?
|
| Bacteroides Infections | 1 | 2024 | 89 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 8 | 2020 | 3637 | 0.230 |
Why?
|
| Inflammation | 11 | 2024 | 10863 | 0.230 |
Why?
|
| Sweetening Agents | 2 | 2018 | 290 | 0.220 |
Why?
|
| Sulfur | 2 | 2021 | 160 | 0.220 |
Why?
|
| Choroid Plexus Neoplasms | 2 | 2001 | 38 | 0.220 |
Why?
|
| Databases, Factual | 6 | 2019 | 8081 | 0.220 |
Why?
|
| Adipose Tissue | 4 | 2020 | 3335 | 0.220 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2007 | 350 | 0.220 |
Why?
|
| Intestinal Neoplasms | 2 | 2018 | 317 | 0.220 |
Why?
|
| Arginase | 1 | 2024 | 81 | 0.220 |
Why?
|
| Probability | 4 | 2024 | 2483 | 0.220 |
Why?
|
| Receptors, Leptin | 2 | 2016 | 351 | 0.220 |
Why?
|
| Metabolomics | 3 | 2024 | 1675 | 0.220 |
Why?
|
| Databases, Genetic | 6 | 2022 | 1754 | 0.220 |
Why?
|
| Waist Circumference | 4 | 2024 | 935 | 0.220 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 117 | 0.210 |
Why?
|
| Gene Frequency | 4 | 2015 | 3615 | 0.210 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2011 | 614 | 0.210 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2019 | 415 | 0.210 |
Why?
|
| Signal Transduction | 18 | 2024 | 23639 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2003 | 62 | 0.210 |
Why?
|
| Genes | 1 | 2007 | 1824 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2019 | 5342 | 0.210 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15459 | 0.210 |
Why?
|
| HLA-DR Antigens | 2 | 2021 | 606 | 0.210 |
Why?
|
| Feces | 4 | 2024 | 1515 | 0.210 |
Why?
|
| Leukocytes | 3 | 2019 | 2030 | 0.210 |
Why?
|
| Resistin | 1 | 2023 | 172 | 0.210 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 2444 | 0.210 |
Why?
|
| Computer Simulation | 3 | 2024 | 6278 | 0.200 |
Why?
|
| Gene Duplication | 1 | 2003 | 314 | 0.200 |
Why?
|
| Medical History Taking | 2 | 2019 | 776 | 0.200 |
Why?
|
| Rhinitis, Allergic, Perennial | 2 | 2008 | 60 | 0.200 |
Why?
|
| Myeloid Cells | 3 | 2024 | 831 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2015 | 6353 | 0.200 |
Why?
|
| Cytoplasm | 1 | 2007 | 1503 | 0.200 |
Why?
|
| Cyclosporine | 2 | 2005 | 781 | 0.200 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2002 | 96 | 0.200 |
Why?
|
| Preimplantation Diagnosis | 2 | 2003 | 143 | 0.200 |
Why?
|
| Gene Expression Profiling | 10 | 2019 | 9508 | 0.200 |
Why?
|
| Age Factors | 11 | 2021 | 18477 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2003 | 387 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2022 | 12242 | 0.200 |
Why?
|
| Immunotherapy | 1 | 2018 | 4728 | 0.200 |
Why?
|
| Cell Nucleus | 3 | 2008 | 2889 | 0.190 |
Why?
|
| Genetic Markers | 5 | 2021 | 2604 | 0.190 |
Why?
|
| Adiposity | 3 | 2020 | 1888 | 0.190 |
Why?
|
| Sulfur-Reducing Bacteria | 1 | 2021 | 14 | 0.190 |
Why?
|
| Weight Gain | 4 | 2023 | 2357 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2014 | 270 | 0.190 |
Why?
|
| Cell Cycle Proteins | 5 | 2017 | 3464 | 0.190 |
Why?
|
| Quantitative Trait Loci | 3 | 2024 | 2126 | 0.190 |
Why?
|
| Social Sciences | 1 | 2021 | 40 | 0.190 |
Why?
|
| Pedigree | 6 | 2015 | 4545 | 0.190 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2004 | 533 | 0.190 |
Why?
|
| DNA Glycosylases | 1 | 2022 | 125 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2024 | 4220 | 0.190 |
Why?
|
| Monosaccharides | 1 | 2021 | 65 | 0.180 |
Why?
|
| Alkylating Agents | 1 | 2021 | 133 | 0.180 |
Why?
|
| Bacteria | 3 | 2020 | 2226 | 0.180 |
Why?
|
| Angiolipoma | 1 | 2000 | 12 | 0.180 |
Why?
|
| Nuclear Proteins | 8 | 2016 | 5808 | 0.180 |
Why?
|
| Pattern Recognition, Automated | 2 | 2024 | 998 | 0.180 |
Why?
|
| Appendectomy | 1 | 2024 | 442 | 0.180 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 181 | 0.180 |
Why?
|
| Auditory Cortex | 1 | 2004 | 365 | 0.180 |
Why?
|
| Beverages | 4 | 2022 | 822 | 0.180 |
Why?
|
| Base Sequence | 8 | 2016 | 12426 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 2 | 2013 | 251 | 0.180 |
Why?
|
| Chorionic Villi | 1 | 2000 | 53 | 0.180 |
Why?
|
| Magnetoencephalography | 1 | 2004 | 641 | 0.180 |
Why?
|
| Immunophenotyping | 2 | 2016 | 1868 | 0.170 |
Why?
|
| Neonatal Screening | 1 | 2005 | 618 | 0.170 |
Why?
|
| DNA-Cytosine Methylases | 2 | 2010 | 17 | 0.170 |
Why?
|
| Adenomatous Polyps | 1 | 2021 | 109 | 0.170 |
Why?
|
| Tacrolimus | 1 | 2004 | 750 | 0.170 |
Why?
|
| Haplotypes | 2 | 2004 | 2723 | 0.170 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2020 | 361 | 0.170 |
Why?
|
| Cholelithiasis | 1 | 2021 | 408 | 0.170 |
Why?
|
| Influenza, Human | 2 | 2021 | 1540 | 0.170 |
Why?
|
| Chemokine CCL5 | 3 | 2016 | 214 | 0.170 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 137 | 0.170 |
Why?
|
| Prenatal Diagnosis | 2 | 2004 | 1274 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2431 | 0.170 |
Why?
|
| Quinazolines | 4 | 2007 | 1376 | 0.170 |
Why?
|
| Granular Cell Tumor | 1 | 2000 | 48 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 2477 | 0.170 |
Why?
|
| Genome, Human | 5 | 2020 | 4454 | 0.170 |
Why?
|
| Teratoma | 2 | 2001 | 405 | 0.170 |
Why?
|
| Databases as Topic | 2 | 2015 | 475 | 0.160 |
Why?
|
| DNA Repair | 2 | 2019 | 2051 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 4247 | 0.160 |
Why?
|
| Granulocytes | 1 | 2021 | 550 | 0.160 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2011 | 229 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 169 | 0.160 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 219 | 0.160 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2011 | 178 | 0.160 |
Why?
|
| Allergy and Immunology | 2 | 2018 | 175 | 0.160 |
Why?
|
| Trace Elements | 1 | 2020 | 193 | 0.160 |
Why?
|
| Peptides | 3 | 2024 | 4368 | 0.160 |
Why?
|
| Obesity, Abdominal | 2 | 2019 | 375 | 0.160 |
Why?
|
| Bilirubin | 1 | 2020 | 439 | 0.150 |
Why?
|
| Young Adult | 17 | 2023 | 60038 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2021 | 318 | 0.150 |
Why?
|
| Meat Products | 1 | 2018 | 96 | 0.150 |
Why?
|
| Medicine, Ayurvedic | 1 | 2018 | 37 | 0.150 |
Why?
|
| Carcinoid Tumor | 1 | 2000 | 226 | 0.150 |
Why?
|
| Bacterial Toxins | 1 | 2024 | 926 | 0.150 |
Why?
|
| Lipoma | 1 | 2000 | 296 | 0.150 |
Why?
|
| Anastomotic Leak | 1 | 2019 | 171 | 0.150 |
Why?
|
| Hyperplasia | 2 | 2014 | 1154 | 0.150 |
Why?
|
| Polyps | 1 | 2020 | 200 | 0.150 |
Why?
|
| Caffeine | 3 | 2017 | 702 | 0.150 |
Why?
|
| Herpes Zoster Oticus | 2 | 1994 | 7 | 0.150 |
Why?
|
| Gene Expression | 7 | 2021 | 7605 | 0.150 |
Why?
|
| Lymph Node Excision | 2 | 2017 | 1276 | 0.150 |
Why?
|
| Gram-Negative Bacteria | 1 | 2019 | 276 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2020 | 3669 | 0.150 |
Why?
|
| Models, Biological | 5 | 2017 | 9505 | 0.150 |
Why?
|
| Advisory Committees | 2 | 2012 | 797 | 0.150 |
Why?
|
| Protein Array Analysis | 2 | 2012 | 399 | 0.150 |
Why?
|
| Leptin | 3 | 2016 | 1598 | 0.150 |
Why?
|
| Smad4 Protein | 1 | 2018 | 193 | 0.150 |
Why?
|
| Thymus Neoplasms | 1 | 2000 | 278 | 0.150 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2019 | 238 | 0.140 |
Why?
|
| Plant Extracts | 2 | 2015 | 499 | 0.140 |
Why?
|
| Mediastinal Neoplasms | 1 | 2000 | 403 | 0.140 |
Why?
|
| Energy Intake | 4 | 2018 | 2141 | 0.140 |
Why?
|
| Health Transition | 1 | 2017 | 35 | 0.140 |
Why?
|
| Postmenopause | 3 | 2024 | 2519 | 0.140 |
Why?
|
| Diet Surveys | 5 | 2020 | 1161 | 0.140 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2018 | 423 | 0.140 |
Why?
|
| Anastomosis, Surgical | 2 | 2019 | 993 | 0.140 |
Why?
|
| Pandemics | 3 | 2024 | 8751 | 0.140 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2003 | 767 | 0.140 |
Why?
|
| Jews | 1 | 2019 | 358 | 0.140 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 542 | 0.140 |
Why?
|
| Pollen | 2 | 2007 | 81 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2000 | 358 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 1816 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2021 | 2601 | 0.140 |
Why?
|
| Sensitivity and Specificity | 8 | 2024 | 14725 | 0.140 |
Why?
|
| Capillaries | 1 | 2000 | 756 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2012 | 2942 | 0.140 |
Why?
|
| Molecular Biology | 2 | 2013 | 573 | 0.140 |
Why?
|
| Thymidylate Synthase | 1 | 2016 | 74 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2022 | 584 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 2 | 1994 | 159 | 0.130 |
Why?
|
| Nursing Research | 1 | 2017 | 80 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2882 | 0.130 |
Why?
|
| Diet, Mediterranean | 2 | 2021 | 747 | 0.130 |
Why?
|
| Metronidazole | 1 | 2017 | 233 | 0.130 |
Why?
|
| Genetic Variation | 4 | 2020 | 6607 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
| Microbiology | 1 | 2016 | 70 | 0.130 |
Why?
|
| Riboflavin | 1 | 2016 | 107 | 0.130 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 365 | 0.130 |
Why?
|
| Interdisciplinary Studies | 2 | 2020 | 86 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1894 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2024 | 1943 | 0.130 |
Why?
|
| RNA, Messenger | 8 | 2023 | 12813 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 39 | 0.130 |
Why?
|
| DNA | 3 | 2012 | 7213 | 0.130 |
Why?
|
| Toll-Like Receptors | 2 | 2021 | 581 | 0.130 |
Why?
|
| Plants, Edible | 1 | 2015 | 30 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2004 | 1767 | 0.130 |
Why?
|
| Ribotyping | 1 | 2015 | 35 | 0.130 |
Why?
|
| Hyperinsulinism | 1 | 2019 | 401 | 0.130 |
Why?
|
| Problem Solving | 1 | 2018 | 443 | 0.130 |
Why?
|
| Cerebellum | 1 | 2003 | 1515 | 0.130 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 341 | 0.130 |
Why?
|
| Nuts | 1 | 2018 | 265 | 0.130 |
Why?
|
| Infant, Newborn | 7 | 2020 | 26394 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2010 | 276 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1119 | 0.130 |
Why?
|
| Models, Genetic | 3 | 2015 | 3442 | 0.120 |
Why?
|
| Epidemiologic Studies | 3 | 2016 | 681 | 0.120 |
Why?
|
| Mass Screening | 6 | 2022 | 5455 | 0.120 |
Why?
|
| Meat | 2 | 2017 | 586 | 0.120 |
Why?
|
| Health Surveys | 6 | 2020 | 4056 | 0.120 |
Why?
|
| Breast Feeding | 1 | 2023 | 1365 | 0.120 |
Why?
|
| Allied Health Personnel | 1 | 2016 | 156 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2020 | 552 | 0.120 |
Why?
|
| Tumor Necrosis Factors | 1 | 2015 | 109 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 568 | 0.120 |
Why?
|
| Monocytes | 2 | 2021 | 2589 | 0.120 |
Why?
|
| Immunity | 2 | 2021 | 1002 | 0.120 |
Why?
|
| Fruit | 1 | 2020 | 1165 | 0.120 |
Why?
|
| Vegetables | 1 | 2020 | 1202 | 0.120 |
Why?
|
| Kidney Neoplasms | 2 | 2023 | 4299 | 0.120 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.120 |
Why?
|
| Intestine, Small | 2 | 2018 | 1218 | 0.120 |
Why?
|
| Alleles | 7 | 2021 | 6880 | 0.120 |
Why?
|
| Gastrointestinal Tract | 2 | 2018 | 840 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 352 | 0.120 |
Why?
|
| Insulin | 3 | 2019 | 6606 | 0.120 |
Why?
|
| Calcium | 2 | 2019 | 5793 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2024 | 1172 | 0.120 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2014 | 31 | 0.120 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2014 | 87 | 0.120 |
Why?
|
| Benzamides | 3 | 2016 | 1381 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 871 | 0.120 |
Why?
|
| Animals | 26 | 2022 | 169424 | 0.120 |
Why?
|
| Calcium Signaling | 1 | 2019 | 737 | 0.120 |
Why?
|
| Food, Fortified | 1 | 2015 | 189 | 0.120 |
Why?
|
| Nutrition Policy | 1 | 2018 | 467 | 0.110 |
Why?
|
| Saccharin | 1 | 1993 | 20 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 245 | 0.110 |
Why?
|
| Treatment Outcome | 15 | 2023 | 65408 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 781 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1013 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1796 | 0.110 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 674 | 0.110 |
Why?
|
| Adolescent | 21 | 2021 | 89163 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 564 | 0.110 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 55 | 0.110 |
Why?
|
| Estrogens | 2 | 2022 | 1531 | 0.110 |
Why?
|
| Mucin-2 | 1 | 2013 | 50 | 0.110 |
Why?
|
| Infant | 8 | 2023 | 36496 | 0.110 |
Why?
|
| Emergencies | 1 | 2020 | 1222 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 617 | 0.110 |
Why?
|
| Mucociliary Clearance | 1 | 1993 | 81 | 0.110 |
Why?
|
| Environment | 3 | 2014 | 1126 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 1143 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 3438 | 0.110 |
Why?
|
| Esophageal Neoplasms | 3 | 2013 | 1676 | 0.110 |
Why?
|
| Living Donors | 4 | 2005 | 651 | 0.110 |
Why?
|
| Japan | 4 | 2019 | 1418 | 0.110 |
Why?
|
| I-kappa B Kinase | 1 | 2014 | 250 | 0.110 |
Why?
|
| Health Occupations | 3 | 2021 | 225 | 0.110 |
Why?
|
| Biopsy | 4 | 2017 | 6816 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2020 | 2575 | 0.110 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2003 | 1489 | 0.110 |
Why?
|
| Prostaglandins | 1 | 2014 | 398 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2014 | 169 | 0.110 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13589 | 0.110 |
Why?
|
| Pharmacoepidemiology | 1 | 2016 | 352 | 0.100 |
Why?
|
| Time | 1 | 2015 | 546 | 0.100 |
Why?
|
| SEER Program | 2 | 2020 | 1476 | 0.100 |
Why?
|
| Body Weight | 3 | 2023 | 4630 | 0.100 |
Why?
|
| Health Personnel | 5 | 2020 | 3384 | 0.100 |
Why?
|
| Fatty Acids, Volatile | 2 | 2010 | 102 | 0.100 |
Why?
|
| Heteroduplex Analysis | 2 | 2002 | 9 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.100 |
Why?
|
| Oncogene Proteins | 2 | 2014 | 718 | 0.100 |
Why?
|
| Fish Oils | 1 | 2016 | 483 | 0.100 |
Why?
|
| Macrophages | 3 | 2023 | 5797 | 0.100 |
Why?
|
| Emotions | 1 | 2004 | 2772 | 0.100 |
Why?
|
| Retrospective Studies | 14 | 2022 | 81835 | 0.100 |
Why?
|
| Immunologic Factors | 2 | 2021 | 1600 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2021 | 1192 | 0.100 |
Why?
|
| Cecal Neoplasms | 1 | 2012 | 27 | 0.100 |
Why?
|
| Income | 1 | 2021 | 1878 | 0.100 |
Why?
|
| Classification | 1 | 2012 | 128 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1408 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2003 | 3122 | 0.100 |
Why?
|
| Cardiolipins | 1 | 1992 | 82 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2017 | 8331 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 952 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 2465 | 0.100 |
Why?
|
| Sigmoid Neoplasms | 1 | 2012 | 53 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 453 | 0.100 |
Why?
|
| Introns | 2 | 2007 | 971 | 0.100 |
Why?
|
| Pregnancy | 7 | 2020 | 30179 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1993 | 272 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2399 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 4984 | 0.090 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 17149 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2021 | 42620 | 0.090 |
Why?
|
| Homocysteine | 1 | 2014 | 637 | 0.090 |
Why?
|
| Telomerase | 1 | 2016 | 749 | 0.090 |
Why?
|
| Snoring | 1 | 2013 | 209 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2012 | 2450 | 0.090 |
Why?
|
| Minnesota | 1 | 2011 | 338 | 0.090 |
Why?
|
| Placenta | 1 | 2000 | 1724 | 0.090 |
Why?
|
| Cadherins | 1 | 2016 | 906 | 0.090 |
Why?
|
| Rectal Diseases | 1 | 2012 | 142 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2020 | 2422 | 0.090 |
Why?
|
| Disease Progression | 7 | 2018 | 13643 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1036 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2017 | 11674 | 0.090 |
Why?
|
| Sirtuin 1 | 2 | 2009 | 247 | 0.090 |
Why?
|
| Cell Count | 1 | 2015 | 1834 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2012 | 203 | 0.090 |
Why?
|
| Genetic Linkage | 2 | 2009 | 2342 | 0.090 |
Why?
|
| DNA, Viral | 2 | 1994 | 2203 | 0.090 |
Why?
|
| Central Nervous System Neoplasms | 1 | 1999 | 928 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 2 | 1989 | 121 | 0.090 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2008 | 105 | 0.090 |
Why?
|
| Asthma | 4 | 2024 | 6274 | 0.090 |
Why?
|
| Transcobalamins | 1 | 2010 | 21 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5426 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2018 | 2003 | 0.090 |
Why?
|
| Nasal Mucosa | 1 | 1993 | 412 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1120 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15638 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 728 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7895 | 0.090 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 48 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7449 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 3793 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2017 | 1802 | 0.090 |
Why?
|
| Pancreatectomy | 3 | 2020 | 824 | 0.090 |
Why?
|
| Intestines | 2 | 2012 | 1912 | 0.080 |
Why?
|
| Yogurt | 2 | 2020 | 71 | 0.080 |
Why?
|
| Diagnosis, Differential | 7 | 2020 | 13025 | 0.080 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 21157 | 0.080 |
Why?
|
| Optic Neuritis | 1 | 1992 | 175 | 0.080 |
Why?
|
| Forecasting | 1 | 2019 | 2950 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2012 | 3577 | 0.080 |
Why?
|
| Kidney Transplantation | 4 | 2005 | 4285 | 0.080 |
Why?
|
| Colitis | 1 | 2018 | 1244 | 0.080 |
Why?
|
| Proteomics | 3 | 2024 | 3901 | 0.080 |
Why?
|
| Germ Cells | 2 | 2024 | 641 | 0.080 |
Why?
|
| Sleep | 2 | 2017 | 4796 | 0.080 |
Why?
|
| Carrier Proteins | 3 | 2007 | 4948 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2016 | 1087 | 0.080 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 1180 | 0.080 |
Why?
|
| Esophagogastric Junction | 1 | 2011 | 349 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2011 | 387 | 0.080 |
Why?
|
| Body Height | 1 | 2015 | 1568 | 0.080 |
Why?
|
| DNA Copy Number Variations | 4 | 2019 | 2046 | 0.080 |
Why?
|
| Oncogenes | 2 | 2019 | 1235 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 7467 | 0.080 |
Why?
|
| Comorbidity | 4 | 2016 | 10601 | 0.080 |
Why?
|
| JC Virus | 1 | 2009 | 87 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 507 | 0.080 |
Why?
|
| Sulfonium Compounds | 1 | 2007 | 3 | 0.080 |
Why?
|
| Arylsulfonates | 1 | 2007 | 9 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2017 | 3813 | 0.080 |
Why?
|
| ROC Curve | 2 | 2020 | 3623 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5891 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 2538 | 0.070 |
Why?
|
| Kidney Glomerulus | 4 | 1997 | 569 | 0.070 |
Why?
|
| Tea | 2 | 2023 | 290 | 0.070 |
Why?
|
| Europe | 3 | 2020 | 3439 | 0.070 |
Why?
|
| Chromosome Mapping | 3 | 2024 | 4622 | 0.070 |
Why?
|
| Pyrimidines | 3 | 2016 | 3050 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2016 | 875 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2021 | 848 | 0.070 |
Why?
|
| Health Status | 1 | 2001 | 4096 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2018 | 2696 | 0.070 |
Why?
|
| Histamine H1 Antagonists | 1 | 2008 | 101 | 0.070 |
Why?
|
| Mucormycosis | 1 | 1989 | 102 | 0.070 |
Why?
|
| DNA Primers | 2 | 2002 | 2825 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 17637 | 0.070 |
Why?
|
| Ki-67 Antigen | 2 | 2000 | 631 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 3619 | 0.070 |
Why?
|
| Cedrus | 1 | 2007 | 2 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2012 | 635 | 0.070 |
Why?
|
| Barrett Esophagus | 1 | 2011 | 494 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 240 | 0.070 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 2006 | 8 | 0.070 |
Why?
|
| Anthocyanins | 2 | 2018 | 80 | 0.070 |
Why?
|
| Internationality | 1 | 2012 | 1007 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 3105 | 0.070 |
Why?
|
| Pancreas | 3 | 2020 | 1703 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1462 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1254 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 2 | 2024 | 2705 | 0.070 |
Why?
|
| Anti-Allergic Agents | 1 | 2007 | 157 | 0.070 |
Why?
|
| Genome, Bacterial | 1 | 2011 | 798 | 0.070 |
Why?
|
| Boston | 2 | 2017 | 9359 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 3111 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2010 | 1640 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 900 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2901 | 0.060 |
Why?
|
| Social Class | 1 | 2015 | 2000 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2024 | 20232 | 0.060 |
Why?
|
| Diet Records | 2 | 2018 | 427 | 0.060 |
Why?
|
| Collagen Type II | 1 | 2006 | 151 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 1905 | 0.060 |
Why?
|
| Garcinia cambogia | 1 | 2005 | 1 | 0.060 |
Why?
|
| Child | 9 | 2020 | 80856 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1604 | 0.060 |
Why?
|
| Genes, Neoplasm | 2 | 2018 | 371 | 0.060 |
Why?
|
| Probiotics | 1 | 2009 | 382 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2013 | 10490 | 0.060 |
Why?
|
| Quality Control | 3 | 2014 | 835 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 606 | 0.060 |
Why?
|
| Neuralgia | 1 | 2012 | 620 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2014 | 5709 | 0.060 |
Why?
|
| RNA Stability | 1 | 2007 | 322 | 0.060 |
Why?
|
| Fibrous Dysplasia, Monostotic | 1 | 2004 | 8 | 0.060 |
Why?
|
| Computational Biology | 1 | 2017 | 3549 | 0.060 |
Why?
|
| Menopause | 2 | 2024 | 1650 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1382 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2017 | 6429 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 664 | 0.060 |
Why?
|
| Citrates | 1 | 2005 | 134 | 0.060 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 333 | 0.060 |
Why?
|
| Foramen Magnum | 1 | 2004 | 41 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 781 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1489 | 0.060 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2004 | 39 | 0.060 |
Why?
|
| Registries | 4 | 2019 | 8372 | 0.060 |
Why?
|
| Germany | 2 | 2018 | 882 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1389 | 0.060 |
Why?
|
| Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3145 | 0.060 |
Why?
|
| Renal Circulation | 1 | 2005 | 291 | 0.060 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2024 | 44 | 0.060 |
Why?
|
| Melanoma | 2 | 2014 | 5740 | 0.060 |
Why?
|
| Sinusitis | 1 | 1993 | 995 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2067 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19035 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2009 | 2103 | 0.060 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 63 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4877 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1882 | 0.060 |
Why?
|
| Sleep Stages | 1 | 2008 | 702 | 0.060 |
Why?
|
| Lung | 1 | 2002 | 10090 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2331 | 0.060 |
Why?
|
| Cause of Death | 3 | 2021 | 3727 | 0.060 |
Why?
|
| Regeneration | 1 | 2012 | 1527 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 9261 | 0.050 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2004 | 125 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 5490 | 0.050 |
Why?
|
| Renal Artery | 1 | 2005 | 353 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2021 | 1051 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1614 | 0.050 |
Why?
|
| Immunosuppressive Agents | 3 | 2005 | 4213 | 0.050 |
Why?
|
| Autoantibodies | 1 | 1992 | 2131 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 8559 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2016 | 12176 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1930 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 10358 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2005 | 350 | 0.050 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2667 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2006 | 772 | 0.050 |
Why?
|
| Mice | 12 | 2018 | 82051 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2292 | 0.050 |
Why?
|
| Posture | 2 | 2004 | 956 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2428 | 0.050 |
Why?
|
| C-Peptide | 1 | 2024 | 444 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2007 | 946 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Vimentin | 2 | 2000 | 257 | 0.050 |
Why?
|
| Body Composition | 1 | 2011 | 2455 | 0.050 |
Why?
|
| Poultry | 1 | 2022 | 80 | 0.050 |
Why?
|
| Allelic Imbalance | 1 | 2022 | 77 | 0.050 |
Why?
|
| Necrosis | 1 | 2006 | 1622 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2016 | 9379 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5367 | 0.050 |
Why?
|
| Stromal Cells | 2 | 2021 | 1335 | 0.050 |
Why?
|
| Arthrogryposis | 1 | 2002 | 69 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2017 | 4861 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2022 | 192 | 0.050 |
Why?
|
| Magnetics | 1 | 2004 | 599 | 0.050 |
Why?
|
| Medical Records | 1 | 2007 | 1413 | 0.050 |
Why?
|
| Metaplasia | 1 | 2002 | 326 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2004 | 1743 | 0.050 |
Why?
|
| Prevalence | 3 | 2023 | 15879 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 9623 | 0.050 |
Why?
|
| Testis | 1 | 2005 | 783 | 0.050 |
Why?
|
| Electromyography | 2 | 2004 | 1399 | 0.050 |
Why?
|
| Colon, Descending | 1 | 2021 | 6 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2004 | 625 | 0.050 |
Why?
|
| Colon, Ascending | 1 | 2021 | 14 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2002 | 240 | 0.050 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2004 | 336 | 0.050 |
Why?
|
| Colon, Transverse | 1 | 2021 | 24 | 0.050 |
Why?
|
| Massachusetts | 2 | 2020 | 8905 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 383 | 0.040 |
Why?
|
| Quality of Life | 2 | 2008 | 13497 | 0.040 |
Why?
|
| Colon, Sigmoid | 1 | 2021 | 124 | 0.040 |
Why?
|
| Microcomputers | 1 | 2000 | 140 | 0.040 |
Why?
|
| Forensic Medicine | 1 | 2000 | 64 | 0.040 |
Why?
|
| Cecum | 1 | 2021 | 232 | 0.040 |
Why?
|
| Telencephalon | 1 | 2001 | 142 | 0.040 |
Why?
|
| Health Promotion | 1 | 2012 | 2215 | 0.040 |
Why?
|
| Proctoscopy | 1 | 2020 | 40 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2015 | 3524 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 3198 | 0.040 |
Why?
|
| Fructose | 1 | 2022 | 285 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2004 | 1253 | 0.040 |
Why?
|
| Papilloma | 1 | 2001 | 142 | 0.040 |
Why?
|
| Choriocarcinoma | 1 | 2000 | 121 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2021 | 168 | 0.040 |
Why?
|
| Hemangioma, Capillary | 1 | 2000 | 64 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2003 | 465 | 0.040 |
Why?
|
| Mannose-Binding Lectin | 1 | 2021 | 145 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2020 | 51 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 2021 | 148 | 0.040 |
Why?
|
| Neoplasm Metastasis | 4 | 2017 | 4931 | 0.040 |
Why?
|
| Sudden Infant Death | 1 | 2002 | 293 | 0.040 |
Why?
|
| Stem Cells | 1 | 2012 | 3538 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 165 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 353 | 0.040 |
Why?
|
| Masks | 1 | 2022 | 215 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1999 | 68 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 267 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3974 | 0.040 |
Why?
|
| Cholecystectomy | 1 | 2021 | 409 | 0.040 |
Why?
|
| Cathepsin D | 1 | 1999 | 59 | 0.040 |
Why?
|
| Neoplasm Seeding | 1 | 2019 | 85 | 0.040 |
Why?
|
| Beclomethasone | 1 | 1999 | 38 | 0.040 |
Why?
|
| Mosaicism | 1 | 2002 | 481 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2009 | 12450 | 0.040 |
Why?
|
| Spain | 1 | 2020 | 491 | 0.040 |
Why?
|
| Canada | 1 | 2024 | 2143 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2013 | 1064 | 0.040 |
Why?
|
| Keratins | 1 | 2000 | 502 | 0.040 |
Why?
|
| Algorithms | 3 | 2017 | 14157 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3590 | 0.040 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 103 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 1077 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26348 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2024 | 756 | 0.040 |
Why?
|
| Reaction Time | 1 | 2004 | 2102 | 0.040 |
Why?
|
| Nasal Polyps | 2 | 1999 | 409 | 0.040 |
Why?
|
| Placenta Diseases | 1 | 2000 | 199 | 0.040 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 495 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2001 | 248 | 0.040 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 2010 | 0.040 |
Why?
|
| Prevotella | 1 | 2017 | 81 | 0.040 |
Why?
|
| Ependymoma | 1 | 2001 | 324 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2000 | 762 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 192 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 164 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 556 | 0.040 |
Why?
|
| Calibration | 1 | 2020 | 823 | 0.040 |
Why?
|
| Bacteroides | 1 | 2017 | 165 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 329 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 11928 | 0.030 |
Why?
|
| Gene Rearrangement | 2 | 2013 | 1139 | 0.030 |
Why?
|
| Homozygote | 1 | 2002 | 1779 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 2433 | 0.030 |
Why?
|
| Autopsy | 1 | 2000 | 1013 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 861 | 0.030 |
Why?
|
| Hematuria | 2 | 1995 | 233 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6320 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| Cotinine | 1 | 2017 | 207 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 1985 | 922 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1986 | 1802 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 2 | 2004 | 2489 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1660 | 0.030 |
Why?
|
| Fibroma | 1 | 1998 | 201 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2000 | 452 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2004 | 4040 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1395 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2001 | 1727 | 0.030 |
Why?
|
| Flavones | 1 | 2015 | 68 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 138 | 0.030 |
Why?
|
| Flavanones | 1 | 2015 | 75 | 0.030 |
Why?
|
| Orbital Neoplasms | 1 | 1998 | 223 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 757 | 0.030 |
Why?
|
| Self Report | 2 | 2020 | 3771 | 0.030 |
Why?
|
| Flavonols | 1 | 2015 | 85 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2001 | 681 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1364 | 0.030 |
Why?
|
| World Health Organization | 1 | 2021 | 1327 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2013 | 2942 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2021 | 2932 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 949 | 0.030 |
Why?
|
| Apoptosis | 2 | 2013 | 9526 | 0.030 |
Why?
|
| Imidazoles | 2 | 2014 | 1174 | 0.030 |
Why?
|
| Age Distribution | 1 | 2021 | 2881 | 0.030 |
Why?
|
| Food Handling | 1 | 2015 | 158 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2018 | 349 | 0.030 |
Why?
|
| Indoles | 2 | 2014 | 1834 | 0.030 |
Why?
|
| Oral Health | 1 | 2020 | 494 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1997 | 303 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Anthropometry | 1 | 2019 | 1343 | 0.030 |
Why?
|
| Somatostatin | 1 | 2016 | 448 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1909 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 20763 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 993 | 0.030 |
Why?
|
| DNA Damage | 1 | 2024 | 2461 | 0.030 |
Why?
|
| Graft Survival | 1 | 2005 | 3890 | 0.030 |
Why?
|
| Testosterone | 2 | 2021 | 2493 | 0.030 |
Why?
|
| Glutathione | 1 | 1996 | 587 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1575 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 516 | 0.030 |
Why?
|
| Glioma | 2 | 1999 | 3523 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 2001 | 1386 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2021 | 2640 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 370 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Estradiol | 1 | 2021 | 1948 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2015 | 431 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 614 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2014 | 253 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2014 | 1988 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 210 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
| Telomere | 1 | 2019 | 942 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2013 | 125 | 0.030 |
Why?
|
| Histamine Release | 1 | 1993 | 134 | 0.030 |
Why?
|
| Fixatives | 1 | 2012 | 90 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2006 | 751 | 0.030 |
Why?
|
| Transfection | 2 | 2014 | 5767 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2207 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2018 | 1333 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 7602 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2008 | 826 | 0.030 |
Why?
|
| Oximes | 1 | 2014 | 304 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 1014 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2003 | 2959 | 0.030 |
Why?
|
| Proteinuria | 1 | 1995 | 613 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2012 | 195 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2024 | 2347 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 2 | 2014 | 2834 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1421 | 0.020 |
Why?
|
| Intestine, Large | 1 | 2011 | 69 | 0.020 |
Why?
|
| Cysteine | 1 | 1996 | 895 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2013 | 330 | 0.020 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1992 | 61 | 0.020 |
Why?
|
| Information Systems | 1 | 2013 | 397 | 0.020 |
Why?
|
| Rats | 5 | 2012 | 23839 | 0.020 |
Why?
|
| RNA Interference | 2 | 2011 | 2832 | 0.020 |
Why?
|
| Cardia | 1 | 2011 | 61 | 0.020 |
Why?
|
| Endoscopy | 1 | 2021 | 1857 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 432 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 1993 | 148 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2004 | 5994 | 0.020 |
Why?
|
| Language | 1 | 2000 | 1557 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2038 | 0.020 |
Why?
|
| Carbon | 1 | 2014 | 671 | 0.020 |
Why?
|
| Eating | 1 | 2018 | 1538 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 856 | 0.020 |
Why?
|
| Premenopause | 1 | 2015 | 1039 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18390 | 0.020 |
Why?
|
| Aberrant Crypt Foci | 1 | 2010 | 12 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 1734 | 0.020 |
Why?
|
| Recurrence | 2 | 2018 | 8510 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 290 | 0.020 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1992 | 167 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3594 | 0.020 |
Why?
|
| Parents | 1 | 2004 | 3596 | 0.020 |
Why?
|
| Facial Paralysis | 1 | 1994 | 346 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2286 | 0.020 |
Why?
|
| Amylose | 1 | 2009 | 3 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 357 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1760 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 770 | 0.020 |
Why?
|
| Starch | 1 | 2009 | 81 | 0.020 |
Why?
|
| Ammonia | 1 | 2010 | 249 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2014 | 4180 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 2009 | 548 | 0.020 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 348 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1643 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6740 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 979 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 2017 | 0.020 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2008 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 325 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2021 | 3076 | 0.020 |
Why?
|
| Butyrophenones | 1 | 2008 | 15 | 0.020 |
Why?
|
| Chlorpheniramine | 1 | 2008 | 13 | 0.020 |
Why?
|
| Terfenadine | 1 | 2008 | 15 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3790 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 1232 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3906 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3586 | 0.020 |
Why?
|
| Dibenzazepines | 1 | 2008 | 26 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3062 | 0.020 |
Why?
|
| Reference Values | 2 | 2012 | 4941 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1343 | 0.020 |
Why?
|
| Dibenzoxepins | 1 | 2008 | 28 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6135 | 0.020 |
Why?
|
| Fasting | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 628 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14483 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 1997 | 1257 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5371 | 0.020 |
Why?
|
| Acute Disease | 2 | 2016 | 7245 | 0.020 |
Why?
|
| Metagenome | 1 | 2011 | 465 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2742 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2531 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 79 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5880 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3790 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 2184 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 1044 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1609 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1997 | 2102 | 0.020 |
Why?
|
| Urticaria | 1 | 2008 | 151 | 0.020 |
Why?
|
| Adenocarcinoma, Scirrhous | 1 | 1986 | 5 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 2969 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 355 | 0.020 |
Why?
|
| Standard of Care | 1 | 2010 | 571 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5042 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 352 | 0.020 |
Why?
|
| Women's Health | 1 | 2016 | 2079 | 0.020 |
Why?
|
| Liver | 2 | 2005 | 7575 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2015 | 1197 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2491 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 3237 | 0.020 |
Why?
|
| Azacitidine | 1 | 2007 | 336 | 0.020 |
Why?
|
| Radioallergosorbent Test | 1 | 1985 | 19 | 0.020 |
Why?
|
| Cell Line | 2 | 2014 | 15610 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1781 | 0.020 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2005 | 25 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1995 | 2565 | 0.020 |
Why?
|
| Mast Cells | 1 | 1993 | 1407 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 3635 | 0.020 |
Why?
|
| Anaphylatoxins | 1 | 1985 | 21 | 0.020 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2005 | 22 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2730 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4022 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2005 | 131 | 0.020 |
Why?
|
| Analgesics | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 6029 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3708 | 0.020 |
Why?
|
| Movement | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 1992 | 975 | 0.010 |
Why?
|
| Epithelium | 1 | 2009 | 1610 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5827 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2004 | 97 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2004 | 163 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2007 | 890 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14766 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 1357 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2841 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 326 | 0.010 |
Why?
|
| Spinal Cord Diseases | 1 | 1986 | 293 | 0.010 |
Why?
|
| Otitis Media with Effusion | 1 | 1985 | 115 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5223 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 11206 | 0.010 |
Why?
|
| Azathioprine | 1 | 2005 | 354 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5508 | 0.010 |
Why?
|
| Histones | 1 | 2013 | 2596 | 0.010 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 467 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 22365 | 0.010 |
Why?
|
| Aging | 2 | 1996 | 8762 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 882 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 344 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 4202 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2009 | 1277 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2012 | 1606 | 0.010 |
Why?
|
| Heart-Assist Devices | 1 | 1993 | 1292 | 0.010 |
Why?
|
| Health Behavior | 1 | 2013 | 2649 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1989 | 1322 | 0.010 |
Why?
|
| Aneurysm | 1 | 2005 | 338 | 0.010 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 230 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2006 | 843 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 1510 | 0.010 |
Why?
|
| Tape Recording | 1 | 2000 | 77 | 0.010 |
Why?
|
| Cytokines | 1 | 2016 | 7440 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8201 | 0.010 |
Why?
|
| Temperature | 1 | 2007 | 2237 | 0.010 |
Why?
|
| Cadaver | 1 | 2005 | 1362 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 734 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 2399 | 0.010 |
Why?
|
| Software Design | 1 | 2000 | 173 | 0.010 |
Why?
|
| Skin | 1 | 2014 | 4520 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2004 | 1208 | 0.010 |
Why?
|
| Organ Size | 1 | 2005 | 2268 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1995 | 3762 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1894 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1989 | 2324 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9066 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1833 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1664 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 1915 | 0.010 |
Why?
|
| Powders | 1 | 1999 | 79 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2005 | 964 | 0.010 |
Why?
|
| Cellulose | 1 | 1999 | 118 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2004 | 912 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 1176 | 0.010 |
Why?
|
| Eye Enucleation | 1 | 1998 | 128 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 10784 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 9177 | 0.010 |
Why?
|
| Rhinitis | 1 | 1985 | 751 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3436 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1998 | 217 | 0.010 |
Why?
|
| Maleates | 1 | 1996 | 18 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1996 | 32 | 0.010 |
Why?
|
| Cystathionine beta-Synthase | 1 | 1996 | 27 | 0.010 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 1996 | 36 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1999 | 707 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2003 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6527 | 0.010 |
Why?
|
| Cystine | 1 | 1996 | 93 | 0.010 |
Why?
|
| Pyridines | 1 | 2008 | 2888 | 0.010 |
Why?
|
| Gold Sodium Thiomalate | 1 | 1995 | 10 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1998 | 656 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1996 | 262 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2005 | 2377 | 0.010 |
Why?
|
| Hemostasis | 1 | 1997 | 470 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 1906 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2007 | 3954 | 0.010 |
Why?
|
| Fibronectins | 1 | 1997 | 725 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2173 | 0.010 |
Why?
|
| Mothers | 1 | 2004 | 2210 | 0.010 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 1993 | 31 | 0.010 |
Why?
|
| Ascaris | 1 | 1993 | 26 | 0.010 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 1993 | 41 | 0.010 |
Why?
|
| Bordetella pertussis | 1 | 1993 | 45 | 0.010 |
Why?
|
| Mucin-1 | 1 | 1998 | 538 | 0.010 |
Why?
|
| Antigens, Helminth | 1 | 1993 | 68 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 2562 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 2419 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1993 | 277 | 0.010 |
Why?
|
| Complement C1q | 1 | 1992 | 93 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2005 | 4505 | 0.010 |
Why?
|
| Mesothelioma | 1 | 1998 | 811 | 0.010 |
Why?
|
| Complement C4 | 1 | 1992 | 216 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1992 | 349 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1999 | 1089 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1891 | 0.000 |
Why?
|
| Immunization | 1 | 1993 | 1220 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1992 | 990 | 0.000 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 986 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1993 | 1150 | 0.000 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1993 | 844 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1528 | 0.000 |
Why?
|
| Mitomycins | 1 | 1986 | 46 | 0.000 |
Why?
|
| Tegafur | 1 | 1986 | 39 | 0.000 |
Why?
|
| Prednisolone | 1 | 1986 | 327 | 0.000 |
Why?
|
| Urination Disorders | 1 | 1986 | 238 | 0.000 |
Why?
|
| Antirheumatic Agents | 1 | 1995 | 1374 | 0.000 |
Why?
|
| Mitomycin | 1 | 1986 | 264 | 0.000 |
Why?
|
| Paralysis | 1 | 1986 | 250 | 0.000 |
Why?
|
| Equipment Design | 1 | 1993 | 3530 | 0.000 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1986 | 338 | 0.000 |
Why?
|
| Uracil | 1 | 1986 | 210 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1985 | 175 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1992 | 2226 | 0.000 |
Why?
|
| Ear, Middle | 1 | 1985 | 341 | 0.000 |
Why?
|
| Kidney | 1 | 1997 | 7064 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15965 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1993 | 3941 | 0.000 |
Why?
|
| Cisplatin | 1 | 1986 | 1661 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1998 | 36840 | 0.000 |
Why?
|